Size and shape effects in the biodistribution of intravascularly injected particles

被引:725
作者
Decuzzi, P. [1 ,2 ,3 ]
Godin, B. [1 ]
Tanaka, T. [1 ]
Lee, S. -Y. [1 ,6 ]
Chiappini, C. [1 ]
Liu, X. [1 ]
Ferrari, M. [1 ,4 ,5 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Dept Nanomed & Biomed Engn, Houston, TX USA
[2] Magna Graecia Univ Catanzaro, Ctr Bio Nanotechnol & Engn Med, Catanzaro, Italy
[3] TASC CNR INFM Lab, Trieste, Italy
[4] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA
[5] Rice Univ, Dept Bioengn, Houston, TX USA
[6] Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA
关键词
Delivery systems; Particle size; Particle shape; Vascular adhesion; RES; DRUG-DELIVERY; NONSPHERICAL PARTICLES; MESOPOROUS SILICON; POROUS SILICON; QUANTUM DOTS; SOLID TUMORS; NANOPARTICLES; CANCER; PHARMACOKINETICS; LIPOSOMES;
D O I
10.1016/j.jconrel.2009.10.014
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Understanding how size and shape can affect the biodistribution of intravascularly injected particles is of fundamental importance both for the rational design of delivery systems and from a standardization and regulatory view point. In this work, uncoated silica spherical beads, with a diameter ranging from 700 nm to 3 mu m, and uncoated non-spherical silicon-based particles, with quasi-hemispherical, cylindrical and discoidal shapes, have been injected into tumor bearing mice. The number of particles accumulating in the major organs and within the tumor mass has been measured through elemental silicon (Si) analysis. For the spherical beads, it has been found that the number of particles accumulating in the non-RES organs reduces monotonically as the diameter d increases, suggesting the use of smaller particles to provide a more uniform tissue distribution. However, discoidal particles have been observed to accumulate more than others in most of the organs but the liver, where cylindrical particles are deposited at a larger extent. These preliminary results support the notion of using sub-micrometer discoidal particles as intravascular carriers to maximize accumulation in the target organ whilst reducing sequestration by the liver. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:320 / 327
页数:8
相关论文
共 46 条
  • [1] Drug delivery systems: Entering the mainstream
    Allen, TM
    Cullis, PR
    [J]. SCIENCE, 2004, 303 (5665) : 1818 - 1822
  • [2] Porous silicon in drug delivery devices and materials
    Anglin, Emily J.
    Cheng, Lingyun
    Freeman, William R.
    Sailor, Michael J.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (11) : 1266 - 1277
  • [3] Role of target geometry in phagocytosis
    Champion, JA
    Mitragotri, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (13) : 4930 - 4934
  • [4] Particle shape: A new design parameter for micro- and nanoscale drug delivery carriers
    Champion, Julie A.
    Katare, Yogesh K.
    Mitragotri, Samir
    [J]. JOURNAL OF CONTROLLED RELEASE, 2007, 121 (1-2) : 3 - 9
  • [5] Renal clearance of quantum dots
    Choi, Hak Soo
    Liu, Wenhao
    Misra, Preeti
    Tanaka, Eiichi
    Zimmer, John P.
    Ipe, Binil Itty
    Bawendi, Moungi G.
    Frangioni, John V.
    [J]. NATURE BIOTECHNOLOGY, 2007, 25 (10) : 1165 - 1170
  • [6] Particle size-dependent organ distribution of gold nanoparticles after intravenous administration
    De Jong, Wim H.
    Hagens, Werner I.
    Krystek, Petra
    Burger, Marina C.
    Sips, Adrienne J. A. M.
    Geertsma, Robert E.
    [J]. BIOMATERIALS, 2008, 29 (12) : 1912 - 1919
  • [7] The receptor-mediated endocytosis of nonspherical particles
    Decuzzi, P.
    Ferrari, M.
    [J]. BIOPHYSICAL JOURNAL, 2008, 94 (10) : 3790 - 3797
  • [8] The adhesive strength of non-spherical particles mediated by specific interactions
    Decuzzi, P.
    Ferrari, M.
    [J]. BIOMATERIALS, 2006, 27 (30) : 5307 - 5314
  • [9] Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution
    Dobrovolskaia, Marina A.
    Aggarwal, Parag
    Hall, Jennifer B.
    McNeil, Scott E.
    [J]. MOLECULAR PHARMACEUTICS, 2008, 5 (04) : 487 - 495
  • [10] Driscoll David F, 2006, Nutr Clin Pract, V21, P381, DOI 10.1177/0115426506021004381